🧬 Understanding the NEBL3 Gene in Cavaliers

What it is, what it means — and what it doesn’t

Over the past few years, you may have started hearing about something called the NEBL3 gene in Cavalier King Charles Spaniels — often spoken about in the same breath as heart disease.

Naturally, this has sparked a lot of curiosity… and also a bit of confusion.

So let’s break it down in a way that actually makes sense — without the fluff, fear, or hype.

🤍 First — why are we even talking about this?

Cavaliers are sadly predisposed to a condition called Mitral Valve Disease (MVD).

It’s the most common health concern in the breed, and something responsible breeders have been working hard to better understand and improve for many years.

Unlike simple genetic conditions, MVD is complex — it doesn’t come from just one gene.Instead, it’s influenced by many genes, plus environmental and structural factors.

That’s where research like NEBL3 comes in.

🧬 So what is the NEBL3 gene?

The NEBL gene (short for nebulette) plays a role in how the heart muscle functions.

The “NEBL3” result you may see in DNA testing refers to a specific genetic marker within that gene.

Rather than causing disease, this marker is thought to:

• Potentially influence how severe MVD becomes

• Possibly be associated with slower progression in some dogs

👉 The important distinction:

NEBL3 is not a disease gene.It does not mean a dog is “clear” or “affected.”

It is simply a risk-associated marker — one small piece of a much bigger puzzle.

📚 How much research is there?

At this stage, research into NEBL3 is:

👉 Early, limited, and still evolving

What we currently know:

• Initial studies (including research out of Australia) found an association between NEBL variants and heart disease severity

• Some follow-up work suggests certain variants may be linked to less severe heart enlargement

• However, studies have involved very small sample sizes — in some cases, as few as 6 dogs

That means:

❗ We do not yet have enough data to draw strong conclusions❗ There is no proof that NEBL3 prevents heart disease❗ It is not reliable as a sole breeding tool

🌍 How common is NEBL3?

At the moment, NEBL3 is still relatively rare.

• Only around 100–120 dogs worldwide have been identified

• Spread across a small number of bloodlines (roughly a dozen family groups globally)

So while it’s becoming more recognised, it is still not widespread within the breed.

⚖️ Should breeders focus on it?

This is where things get really important.

There’s been some discussion in the breeding world about whether NEBL3 should be actively selected for — or even line bred.

Our honest answer?

👉 Not as a primary focus — at least not yet.

Here’s why:

1. It doesn’t prevent MVD

Even dogs with favourable NEBL variants can still develop heart disease.

2. Cavaliers already have limited genetic diversity

Focusing too heavily on a rare marker can:

• Increase inbreeding (COI)

• Narrow the gene pool further

• Accidentally concentrate other health issues

3. MVD is not caused by one gene

Selecting for a single marker in a polygenic condition is unlikely to solve the bigger problem.

4. The data just isn’t strong enough yet

We simply don’t have the long-term, large-scale research needed to make it a reliable breeding priority.

🧠 So what actually matters most?

While genetic research is exciting (and important!), the foundations of responsible breeding haven’t changed.

The most effective approach still includes:

• 🫀 Heart testing by a veterinary cardiologist

• 📊 Maintaining genetic diversity (low COI)

• 🧬 Thoughtful pairing choices — not extremes

• 🐾 Strong focus on temperament and overall health

These are the things that have consistently made a real difference over time.

✨ Where does NEBL3 fit in?

At this stage, NEBL3 is best viewed as:

👉 An interesting and promising piece of research — not a solution

It can be:

• A useful additional data point

• Something to observe and track over time

But not something to:

• Build an entire breeding program around

• Prioritise over proven health practices

• 
  

  🤍 Our approach

  At Sielle Place Cavaliers, our focus has always been on the whole dog — not just one test result.

  We stay up to date with emerging research like NEBL3, and we genuinely value the role it may play as our understanding continues to grow. But we also believe in keeping things in perspective.

  Because the reality is — there is no single “fix” for a complex breed like the Cavalier.

  NEBL3 is an interesting and promising piece of the puzzle, but it’s still only that… a piece.

  Long-term breed health isn’t built on chasing one gene or following trends. It’s built on thoughtful, balanced decisions over time — prioritising heart testing, maintaining genetic diversity, and selecting for soundness, temperament, and overall quality.

  It can be easy to feel overwhelmed by genetics, or to get caught up in new terms and testing as they emerge. But meaningful progress doesn’t come from quick fixes — it comes from consistency, education, and doing what’s right for the breed as a whole.

  That’s the approach we take, and will continue to take 🤍🐾

  And as always, we’re here for open, honest conversations — because informed owners make the very best homes.